Drug intelligence / Profile preview

Xinnaoning

Development stage
Phase 4
Lead developer
Guizhou Jingcheng Pharmaceutical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Xinnaoning is a Traditional Chinese Medicine (TCM) formulation, primarily available as a capsule, used for the treatment of cardiovascular and cerebrovascular diseases. It is specifically indicated for chronic stable angina pectoris associated with "Qi stagnation and blood stasis syndrome" in TCM theory. The formulation is a complex mixture of botanical extracts, including *Ginkgo biloba*, *Salvia miltiorrhiza*, *Panax notoginseng*, and *Pueraria lobata*, which work synergistically to promote blood circulation, resolve blood stasis, and improve blood flow to the heart and brain. It is developed and manufactured by Guizhou Bailing Group Pharmaceutical and has been evaluated in Phase 4 clinical trials to confirm its efficacy and safety in patients with stable angina.

Brand names
XinnaoningXinnaoning Capsule
Other names
Xinnaoning Jiaonang

Beyond the preview

Go deeper on Xinnaoning.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xinnaoning.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call